Cardiology Case wrap-up-Jaynstein (FINAL) Flashcards

1
Q

Case A:
75 yo female with AF
-6 month FU
-CC: On Coumadin – inquiring about switching

A fib INR goal?

A

**2.0-3.0

for mech valve: 2.5-3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AFIB- COUMADIN FAILURE is defined as ?

A

=Thromboembolic event while on Coumadin at a therapeutic level

-You might hear people use this term for a patient who cannot maintain INR within the goal range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Afib coumadin dosing:
What dose of Coumadin was she on when this INR was obtained and if she took the days dose prior to the blood draw

Today, Thursday, INR 1.8
-Last INR 2.3

Current Coumadin dose: 4 mg M/W/F, 3 mg T/TH/S/S

A

she may need 4 mg every day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List meds that cause an increased bleeding risk independent of the INR:

A

NSAIDs, Aspirin, Plavix/ other antiplatelet drugs, gingko biloba, dong quai, fenugreek, chamomile.

Cephalexin and clindamycin have minimal interactions with warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Slide 6

A

look

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AFIB-DIETARY COUNSELING

-what food items are high in vit K?

A
  • Complete avoidance of spinach isn’t necessary
  • Keep Vit K intake relatively constant over time
  • Items very high in Vit K: Spinach, brussel sprouts, collard greens, turnip, mustard greens, kale

Medium Vit K foods: Asparagus, lettuce, cabbage, broccoli, peas, okra, Viactiv chews

Low Vit K foods: avocado, banana, chickpeas, fruit, oil, peppers, seaweed, tomatoes

  • **green tea may alter VKA anticoagulation, and we generally advise patients to limit intake to one or two servings (or less) per day.
  • Severely malnourished patients may be more sensitive to warfarin
  • Weight loss diets: may lead to alterations in warfarin dose requirements due to changes in vitamin K intake or warfarin metabolism; individuals on weight-loss diets generally should have more frequent testing of the INR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pros of Warfarin

A

Cheap
Best for severe or ESRD
Must use in valvular AF
Reversal agent exists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cons of Warfarin

A
  • Many food & drug interactions

- Narrow therapeutic window – need INR checks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pros of DOACs

A
  • Fewer interactions
  • Less ICH and fatal bleeding events
  • No monitoring needed
  • Bridging not needed due to rapid onset/offset

**DOACs - Direct Thrombin Inhibitor and the Direct Factor Xa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cons of DOACs

A
  • Some lack, or are difficult to obtain/costly, +/- reversal agents
  • More expensive
  • **Generally higher rate of GI bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This patient’s CrCl: 29.47 mL/min; Cr 1.5 – pt requires renal dosing on all DOACs–so look at what would be the cheapest option, when can they be initiated

-list ex’s

A

-Dabigatran (Pradaxa): 75 mg PO BID (=Direct Thrombin Inhibitor) –> Start when INR <2.0

Rivaroxaban (Xarelto): 15 mg PO with evening meal (= Direct Factor Xa inhibitor)
–> Start when INR <3.0

Apixiban (Eliquis): 2.5 mg PO BID (=Direct Factor Xa inhibitor) –> Start when INR <2.0

Edoxaban (Savaysa): 30 mg PO daily (=Direct Factor Xa inhibitor)–>Start when INR ≤2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which DOACs are reversible?

A

**Only Coumadin, pradaxa (praxbind), Eliquis and Xarelto (andexXa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe normal dosing for various DOACs

A

-Pradaxa normal dosing: 150 mg PO BID

Xarelto normal dosing: 20 mg PO with evening meal

Eliquis needs lower dose if Cr ≥1.5 and either age ≥80 or weight ≤60 kg. Normal dosing is 5 mg BID

Savaysa: remember not to use in patients with a CrCl >95

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CHA2DS2-VASC score

A
CHF- 1 
hypertension- 1
age ≥ 75 years- 2
DM- 1
stroke or (TIA), - 2
vascular disease-1
age 65 to 74 years- +!
sex category-F- +1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Our patient – HTN, Age > 75, Female
CHA2DS2-VASc score=

At which point do you need to anticoagulate?

A

4

Everybody agrees at 2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Goals for resting HR (rate control)

  • strict ventricular rate < ____
  • lenient ventricular rate < ___
A
  • <80

- <110

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Goals for exertional HR:

  • ventricular HR < ____
  • list ex’s of meds that would work for this Pt
A

<115

-Current rate: 85

Current rate control med: Lopressor 50 mg PO BID

Other options: Toprol XL 50 mg daily, carvedilol (Coreg) 3.125 mg BID, Diltiazem (Cardizem) ER 120 mg daily, Verapamil ER 120-180 mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When does a Pt require digoxin?

A

-Digoxin: probably not needed in this patient: she doesn’t have HFrEF, and her rate is adequately controlled with one agent (not even at max dosing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Case A:
75 yo female with AF
-6 month FU
-CC: On Coumadin – inquiring about switching

Assessment and plan?

A

Meds: Continue Lopressor 50mg BID and MV

  • D/C Coumadin
  • Eliquis 2.5 mg PO BID – can start today

Diagnostics: None today

Patient Education: Bleeding prevention, ASA/NSAID use

Follow-up: within 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Case B:
56yo AA male with HTN
H/O DM and Gout
Current meds: HCTZ, Norvasc, Metformin, Mucinex D

  • Pt currently has BP of 154/94
  • HCTZ can cause ?(list S/E)
A
Hyponatremia
Hypokalemia
Hypomagnesemia
**Can precipitate gout
-Caution in diabetics

(HCTZ- use in caution in patients with diabetes- can increase glucose levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
Mucinex D (guaifenesin & pseudoephedrine):
is assoc. with which S/E?
A

HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Norvasc can cause ________

A

peripheral edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HTN + DM

  • goal BP?
  • ideal meds?
A

130/80
-Diuretics, ACE-I/ARB, CCBs

-For age >60: if either SBP or DBP is above these numbers, treat.
Age >60: Treating to a goal of <150/90 reduces stroke, CHF, and CHD (coronary heart disease).
-In the 30-59 group, there is actually only strong evidence for diastolic BP goals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Amlodipine (Norvasc)

  • onset?
  • duration?
  • metabolism?
A

Onset: 24-48 hours

Time to peak: 6-12 hours

Duration: 24 hours (up to 72)
Metabolism: Hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Amlodipine (Norvasc)

  • life threatening S/E?
  • common S/E?
A

angina/MI, hypotension, pulmonary edema
Use with extreme caution in patients with severe AS(aortic stenosis): can reduce coronary perfusion–> ischemia. Also in CHF patients: reduction in afterload can worsen sx

Common s/e: PERIPHERAL EDEMA, fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Amlodipine (Norvasc):
-starting dose?
Max dose?

A

-2.5 mg (frail, already on other antihypertensives), or 5 mg (usual) daily

Max: 10 mg PO daily

-CCBs work better in AA patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lisinopril:

  • onset?
  • Duration?
  • metabolism?
A
  • 1 hour, peak at 6 hours
  • duration: 24 hrs

not metabolized, excreted in urine as unchanged drug

28
Q

Lisinopril:

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

**Angioedema, cholestatic jaundice (can progress to fulminant hepatic necrosis), hyperkalemia, ARF, hypotension, severe hypersensitivity reactions

–>**Angioedema can also affect the gut, manifesting as abdominal pain. African Americans appear to be at increased risk.

Common s/e: hyperkalemia, increased creatinine, dizziness, cough

Starting dosage: 10 mg PO daily
Max: 40 mg daily

29
Q

Lopressor (Metoprolol Tartrate):

  • onset ?
  • duration?
  • metabolism?
A
  • 1 hr, peaks 1-2 hrs
  • duration variable, dose-related
  • hepatic
30
Q

Lopressor (Metoprolol Tartrate):

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

**AV block, bradycardia, CNS depression, hypotension

Common s/e: hypotension, bradycardia, dizziness

Starting dose: 50 mg BID

Max: 450 mg/day (usual up to 100 mg BID)

note:Can precipitate or worsen symptoms of Raynaud or peripheral vascular disease

31
Q

Toprol XL (Metoprolol Succinate):

  • onset?
  • Duration?
  • metabolism?
A
  • peaks 6-12 hrs
  • 24 hours
  • hepatic
32
Q

Toprol XL (Metoprolol Succinate):

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

AV block, bradycardia, CNS depression, hypotension,

Common s/e: hypotension, bradycardia, dizziness

Starting dose: 12.5- 25 mg daily

Max dose: 200 mg daily

33
Q

Labetalol:
onset?
duration?
-metabolism?

A
  • 20 min PO
  • duration: 8-12 hrs
  • hepatic
34
Q

Labetalol:

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

hypotension, hepatic injury

Common s/e: hypotension, orthostatic hypotension, dizziness, nausea

Starting dose: 100 mg PO BID

Max: 2400 mg/day

35
Q

HCTZ:

  • onsest?
  • duration?
  • metabolism?
A
  • 2 hours
  • duration: 6-12 hrs
  • not metabolized
36
Q

HCTZ:

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

severe electrolyte disturbances, angle-closure glaucoma

Common s/e: hypokalemia, hyponatremia, hypomagnesemia, hypochloremic alkalosis, precipitation of gout

Starting dose: 12.5 – 25 mg PO daily
Max dosage: 50 mg daily (don’t do this! Stick with 25 mg)

37
Q

There are multiple HCTZ combo drugs for consideration:

-list ex’s

A
  • should not use HCTZ as monotherapy, typically given in combo form
  • Losartan/HCTZ–> Hyzaar (ARB + Diuretic)

Benazepril/HCTZ –> Lotensin (ACE-I + Diuretic)

Lisinopril/HCTZ –> Zestoretic (ACE-I + Diuretic)

Metoprolol tartrate/HCTZ –> Lopressor HCT (BB + Diuretic)

Triamterene/HCTZ –> Dyazide or Maxzide (Potassium-sparing + thiazide diuretic)

38
Q

Losartan (Cozaar):
onset?
duration?
-metabolism?

A
  • 6 hrs, peaks in 1 hr

- metabolism: liver

39
Q

Losartan (Cozaar):

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

angioedema, hyperkalemia, hypotension, renal function deterioration

Common s/e: cough, hyperkalemia, increased creatinine

Starting dose: 50 mg daily

Max dose: 100 mg daily

40
Q

Clonidine:

  • peaks?
  • half life?
  • metabolism?
A
  • 1-3 hrs
  • 1/2 life= 12-16 hrs w normal renal fx
  • hepatic
41
Q

Clonidine:

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

bradycardia, CNS depression, hypotension

Common s/e: drowsiness, headache, fatigue, dizziness, transient skin rash, xerostomia**. (note: ppl crash v hard from this med)

Starting dose: 0.1 mg PO BID or transdermal patch 0.1 mg/24 hour patch applied weekly
Max: 2.4 mg/day

42
Q

Diltiazem (Cardizem) ER:

  • peak?
  • 1/2 life?
  • metabolism?
A
  • 10-18 hrs
  • 4-9 hrs
  • hepatic
43
Q

Diltiazem (Cardizem) ER:

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

AV block, bradycardia, SJS, hypotension

Common s/e: peripheral edema, headache, bradycardia, dizziness

Starting dose: 120 – 240 mg daily (for ER capsule with once daily dosing)

Max: 480 mg/day

44
Q

Hydralazine:
peaks?
1/2 life?
metabolism?

A
  • 1-2 hrs
  • 3-7 hrs
  • liver
45
Q

Hydralazine:

  • Life-threatening s/e: ?
  • common s/e?

-starting dose and max dose?

A

**drug-induced lupus-like syndrome, blood dyscrasias, contraindicated in those with CAD (implicated in MI), peripheral neuritis

Common s/e: earache, tachycardia, palpitations, angina, nausea/vomiting, diarrhea

Starting dose: 10 mg PO QID
Max: 300 mg/day

46
Q

Life Style modifications- for HTN

A

Weight loss: DASH diet
Smoking cessation
Exercise
Alcohol in moderation

47
Q

Case B:
56yo AA male with HTN
H/O DM and Gout
Current meds: HCTZ, Norvasc, Metformin, Mucinex D

Plan?

A

Meds:

  • D/C HCTZ and Mucinex D
  • Add Lisinopril 10mg QD
  • Cont Norvasc 10mg QD and (*Metformin 500mg BID)

Diagnostics: No additional labs today

Patient Education: life style modifications

Follow-up: 1 week for BP check, labs

(Check potassium in 1 week!!!
Metformin– watch out, this pt has poor renal fx, may need to d/c metformin soon)

48
Q

Case C:

55 yo male s/p AMI 2 wks ago with stent placement

A

?

49
Q

Hyperlipidemia in CAD Pts:

-primary prevention?

A

Calculate baseline risk for CV events if LDL >100

  • If 10 year risk ≥ 7.5-10% –> statin–>Statins reduce CV RR 20-30%
  • If LDL ≥190

Primary prevention refers to the effort to prevent or delay the onset of ASCVD. Secondary prevention refers to the effort to treat known, clinically significant ASCVD, and to prevent or delay the onset of disease manifestations.

50
Q

Hyperlipidemia in CAD Pts:

-secondary prevention?

A

Lifelong high intensity statin (regardless of LDL)

  • -Atorvastatin (Lipitor) 40 or 80 mg
  • -Rosuvastatin (Crestor) 20 or 40 mg

In secondary prevention, if they don’t tolerate, go to the maximum dose the patient will tolerate.

51
Q

DOC for lowering LDL?

A

**statins

  • A substantial reduction in LDL should occur at the usual starting dose – doubling of a dose produces only an additional 6% decrease.
  • Consider this when deciding to increase a dose vs add an additional medication.
52
Q

What labs should you obtain at baseline prior to starting statin therapy?

A

***LFTs at baseline, 6-12 weeks after initiation or any dose increase, then annually

Contraindications: Liver disease (alcohol abuse), pregnancy

53
Q

Statins:

  • list life-threatening S/E
  • common s/e?
A

**Rhabdomyolysis, ARF, hepatotoxicity, hemorrhagic stroke

Common s/e: photosensitivity, arthralgia’s, GI upset - diarrhea, nasopharyngitis, elevated LFTs

54
Q

Statin related myopathy

-risk factors?

A

-small body frame, multisystem diseases, multiple medications

**Routine monitoring of CPK levels is NOT recommended. Only consider in symptomatic patients.

55
Q

Pts with DES (drug eluding stents) need at least ____ months of dual antiplatelet therapy (DAPT)

A
  • 6-12 months

- -> If patients are free of major or moderate bleeding events at that time, continue for at least 18-24 more months

56
Q

Long-term dual antiplatelet therapy=

-purpose?

A

DAPT- aspirin plus platelet P2Y12 receptor blocker) significantly lowers the risk of stent thrombosis. In addition, there is some evidence to support the idea that it also prevents ischemic events remote from the stented area.

-After 6-12 months of DAPT, the event rates for myocardial infarction, death, stent thrombosis, and major hemorrhage are relatively low and the benefits and risks are almost evenly balanced in most patients.

57
Q

DAPT score predicts:

A

predicts combined ischemic and bleeding risk for patients being considered to continue DAPT therapy beyond 1 year

-DAPT trial showed that the benefit for prolonged DAPT is largely independent of stent type

BMS= (bare metal stent)–has Same recommendations

58
Q

List dosing for DAPT

A

Clopidogrel (Plavix) 75 mg PO daily + ASA 81-325 mg daily
–>Reduces risk for stent thrombosis, MI, death

-ASA should be continued indefinitely in all stented patients

59
Q

Plavix:
Life threatening s/e ?
common s/e?

A

Life threatening s/e: severe bleeding, Thrombotic thrombocytopenic purpura (TTP), agranulocytosis, hypersensitivity reaction, SJS/TEN, aplastic anemia, pancytopenia

Common s/e: Bleeding, pruritis

60
Q

Daily ASA has been shown to reduce CV risk by up to _____%

A

25%

61
Q

ASA:

  • MOA?
  • dosing?
A

MOA: inhibits platelet aggregation

FYI: ASA peak plasma conc can occur within 30 minutes of taking a non-enteric coated pill –can be up to 4 hours if enteric-coated!

Dosing: 325mg really only indicated for AMI and acute ischemic stroke. 81mg QD sufficient for daily use.

62
Q

ASA:

  • interactions?
  • contraindications?
A
  • *NSAIDs

- GI bleeds

63
Q

Anti-Anginal Medications:

-list classes of meds

A
  • BBs
  • Nitrates
  • CCBs
64
Q

BBs:

  • Reduce HR and ____
  • the only anti-anginal med that is proven to improve _______
A
  • contractility

- survival and prevent re-infarction in patients who have had MI

65
Q

Nitrates are 1st line therapy for ______

A

**acute angina sx

66
Q

CCBs cause coronary and peripheral vasodilation and reduce ______

A

contractility

–CCB usually used in combo with BB when monotherapy with BB not adequate

67
Q

slide 38

A

finish